Inhalation Toxicity Study

吸入毒性試験

Our inhalation toxicity studies draw on nearly 40 years of experience and commitment to global standards.
Mediford provides highly reliable data through assured quality at GLP-compliant and fully AAALAC-accredited facilities, utilizing optimal study designs based on extensive experience.

Tailor-made Inhalation Toxicity Study

Inhalation toxicity studies are crucial for meeting regulatory requirements and scientifically validating product safety. Drawing on our extensive experience and technical expertise, we provide customized study designs tailored to the properties, intended uses, and expected human exposure pathways. Even when the purpose of the study is not clearly defined, we work closely with our clients to develop an optimal study strategy. Our services address a range of objectives, including regulatory compliance, product risk reduction, and accumulation and utilization of product safety information within your organization. Please feel free to contact us even in the early stages of your study planning.

Our Contract Achievements

Our strength lies in our diverse know-how gained through abundant experience. We are pleased to present selected contract achievements from our inhalation toxicity studies.

FY2015-2024
Species Route GLP Single dose 2W 4W 13W Others
Monkeys Head-only inhalation exposure OECD GLP 0 0 0 0 0
Pharmaceutical GLP 1 0 0 2 0
Non-GLP 1 1 0 0 0
Mice Whole-body inhalation exposure OECD GLP 0 0 0 0 1
Pharmaceutical GLP 0 0 0 0 0
Non-GLP 2 0 0 0 3
Rats Nose-only inhalation exposure OECD GLP 70 0 6 3 0
Pharmaceutical + OECD 4 0 0 0 0
Pharmaceutical GLP 4 0 1 2 0
Other GLP 3 0 0 0 0
Non-GLP 30 5 5 2 1
Whole-body inhalation exposure OECD GLP 0 0 1 0 0
Pharmaceutical GLP 2 0 2 0 0
Non-GLP 4 0 0 0 0

Overview of Inhalation Toxicity Study

Inhalation toxicity studies are non-clinical assessments in which test substances are administered via spontaneous respiration. These studies aim to evaluate the safety of substances that may be exposed to humans through the respiratory tract. The objective of these studies is to examine a wide range of substances, including pharmaceutical products intentionally administered via the respiratory tract, as well as various materials unintentionally inhaled in workplaces and home environments—such as agrochemicals, chemical products, household products, and emissions from electronic devices.
Therefore, regulatory authorities may require the conduct of inhalation toxicity studies, depending on the route of administration for pharmaceuticals, the physical properties of new active ingredients for agrochemicals, or the physicochemical properties and/or exposure scenarios for chemical products.

Main test substances

医薬品(吸入医薬品、殺虫剤等)
Pharmaceuticals
(Inhalation drugs, insecticides)
農薬(原体、製剤)
Agrochemicals
(Technical grade, formulations)
化学品(ガス、揮発性物質など)
Chemical products
(Gas, volatile agents)

Household products* commonly used in our daily lives are also included as study subjects.

スプレー製品・防水スプレー・整髪料・制汗剤・防臭剤
Spray products
(Water-proof spray / Hair styling products / Antiperspirants / Deodorants)
Air fresheners
Substances released from home appliances

*: Products that may be inhaled by humans due to emissions, including evaporation and spraying.

List of Inhalation Toxicity study

Mediford conducts a variety of inhalation toxicity studies in compliance with GLP standards and can flexibly accommodate different combinations of test systems. For nearly 40 years, we have conducted a wide range of inhalation toxicity studies tailored to the specific characteristics of various substances, accumulating extensive experience and technical expertise in this field. Leveraging our decades of expertise, we deliver high-quality, end-to-end inhalation testing solutions—from atmosphere generation and characterization to detailed respiratory histopathology.

Study type Characteristics of test atmosphere Species Exposure route
  • Acute inhalation toxicity study
    (Single-dose inhalation toxicity study)
  • Sub-acute inhalation toxicity study
    (28-day study)
  • Sub-chronic inhalation toxicity study (90-day study)
    (Repeated-dose inhalation toxicity study)
  • Gas
  • Vapor
  • Mist (liquid)
  • Dust (solid)
  • Fumigation
  • Others
  • Rats
  • Mice
  • Cynomolgus monkeys (mist exposure only)
  • Guinea pigs
  • Rabbits (available by negotiation)
  • Nose-only inhalation exposure
  • Whole-body inhalation exposure
  • Head-only inhalation exposure
    (available only for monkeys)

Types of Equipment

Inhalation toxicity studies require a high level of expertise in both the selection and use of equipment. We provide best practices by ensuring the appropriate configuration and use of equipment, backed by years of technical expertise and experience.

Test atmosphere preparation

ミスト
Mist
ダスト
Dust

Test atmosphere exposure

Head-only inhalation exposure for monkeys
Head-only inhalation exposure for monkeys
Nose-only inhalation exposure
Nose-only inhalation exposure
Whole-body inhalation exposure
Whole-body inhalation exposure

Test Atmosphere Characterization

We provide reliable test atmosphere characterization, backed by extensive expertise and a proven track record. We deliver highly accurate data for all aspects, including precise control of exposure concentration, particle size distribution, and environmental conditions.

Exposure concentration measurement

Gravimetric analysis method:
  • Sample collection using a glass fiber filter
  • Measurement of collected air volume
  • Measurement of filter weight before and after collection
Chemical analysis method:
  • The concentration of the test substance in the test atmosphere is quantified by chemical analysis (e.g., gas chromatography or high-performance liquid chromatography) as an alternative to gravimetric analysis.

Highly reliable data obtained through these methods are ensured by thorough validation.

Validation items:
  • Collection efficiency, recovery rate, weighing suitability, adsorption and permeability
  • Test atmosphere sampling
    (suction-based method)
  • Sampling volume measurement
  • Gravimetric analysis
    or
    Chemical analysis
Test Atmosphere Characterization

Particle size distribution

In inhalation toxicity studies, particle size is measured as aerodynamic diameter, which is an important index to particle deposition in the respiratory tract. These results are used to evaluate the location and quantity of particle deposition in the respiratory tract.

Calculated parameters:
  • Mass Median Aerodynamic Diameter: MMAD
  • Geometric Standard Deviation: GSD

Measurement of aerodynamic diameter.
Equipment: Cascade impactor

A cascade impactor is a device used to collect and classify airborne particles by sequentially passing them through multiple stages. Each stage consists of a nozzle (jet) and an impaction plate (sampling plate). The air velocity increases at each stage by sequentially reducing the diameter of the jet. Particles entering the impactor are separated by size as they are impacted onto plates due to increasing air velocity.

Stage
No.
Cutoff
diameter
(μm)
Sample
weight
ratio
1 5.8 14.9%
2 3.67 37.1%
3 2.41 24.2%
4 1.49 11.9%
5 1.09 6.2%
6 0.75 3.6%
7 0.34 1.5%
Measurement of aerodynamic diameter.<br>Equipment: Cascade impactor

Environmental condition

Temperature and relative humidity are routinely measured, and oxygen concentration is also measured when low levels are expected.

Guidelines

We are capable of conducting a wide range of inhalation toxicity studies in compliance with both domestic and international guidelines. The data generated from our studies are suitable for submission to regulatory authorities.

Applicable guidelines

Acute inhalation toxicity study (single dose toxicity study)
  • OECD guideline No. 403 (Traditional protocol)
  • OECD guideline No. 433 (Fixed concentration procedures)
  • OECD guideline No. 436 (Acute toxic class method)
  • EPA health effect test guideline (OPPTS/OCSPP) 870.1300
Sub-acute inhalation toxicity study (28-day or 4-week repeated dose toxicity study)
  • OECD guideline No. 412
Sub-chronic inhalation toxicity study (90-day or 13-week repeated dose toxicity study)
  • OECD guideline No. 413
  • EPA health effect test guideline (OPPTS/OCSPP) 870.3645

Regulatory Compliance

We propose study designs that comply with toxicity study guidelines, as well as the regulatory requirements of domestic and international authorities that require inhalation toxicity study data.

Major Regulatory Requirements:

  • Acute inhalation toxicity test required when applying for exemption under the “Criteria for Determining Poisonous and Deleterious Substances” of the Poisonous and Deleterious Substances Control Act (Japan)
  • Chemical Substances Control Law (Japan): A 28-day repeated inhalation toxicity test using mammals is required for notification of a new chemical substance
  • European Regulations (CLP/REACH): Classification of inhalation toxicity based on the European Council Directive (EC) regarding hazard classification and labelling
  • IMDG Code (maritime transport): Classification of inhalation toxicity based on IMO (International Maritime Organization) regulations for maritime transport of dangerous goods
  • IATA Dangerous Goods Regulations (air transport): Toxicity data required for hazard classification and labelling during air transport, based on ICAO-TI and IATA-DGR